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Hypertension is an increasingly important medical and
public health issue.1 In developing countries like
Pakistan, India, and China, where hypertension has
reached epidemic proportions affecting more than 20%
of the adult population, the control rates are less than
6%.2 In trials comparing diuretics with other classes of
antihypertensive agents, diuretics have been virtually
unsurpassed in preventing the cardiovascular compli-
cations of hypertension.3
Many physicians tend not to prescribe thiazide diuretics
as first line antihypertensive agents recommended by
most international guidelines.4 Low prescribing rate of
thiazides has been attributed to concerns about
electrolyte disturbance. Diuretics tend to be under used
in management of hypertension due to concern of
electrolyte imbalance. Hence, this study was conducted
to determine association of hyponatremia in hyper-
tensive patients using diuretic as an antihypertensive
therapy.
This was a case control study conducted at the Aga
Khan University Hospital, Karachi, Pakistan. Ethical
approval from the ethics review committee of the Aga
Khan University Hospital (ERC/AKU;16-08-2009) was
taken for conduct of the study.
All adult inpatients (> 18 years), over a 1.5 years period
(2008 - 2009), who were known hypertensive
(diagnosed on having an average blood pressure of
≥ 140/90 mmHg on atleast 2 clinic visit) and were on
antihypertensive therapy for atleast 6 weeks were
included.5 Cases were defined as hypertensive with
hyponatremia (sodium < 135 mmol/l) on admission.6
Controls were defined as hypertensive without
hyponatremia (sodium > 135 mmol/l) on admission.
Cases and controls were not matched for any
characteristics. Exposure was defined as the use of
diuretics at 6 weeks prior to recruitment. This was
assessed by recording data on antihypertensive therapy.
This sample was drawn using computerized medical
record system International Classification of Diseases -
9-coordination and maintenance (ICD-9-CM) at health
information management system in the hospital.
Patients admitted either with primary or secondary
diagnosis of hypertension was used for selection
through the ICD-9-CM. Cases were selected if in
addition these patient had associated diagnosis of
hyponatremia and controls were selected if the
associated diagnosis was not hyponatremia. Those
patients who did not have a documented record of the
antihypertensive therapy or who had recent history of
fluid loss (for example diarrhea) were excluded from the
study.
Primary outcome variable was hyponatremia in
hypertensives. Data on demographics, co-morbid
conditions, type and number of antihypertensive agents
and mean duration of antihypertensive therapy was
recorded by trained data collectors, from the medical
record of the patient. A history of physician-diagnosed
diabetes, stroke, ischemic heart disease (IHD), chronic
kidney disease (CKD) as documented in the medical
records was noted.
Statistical Package for Social Sciences (SPSS) version
17.1 was used for the analysis. Mean and standard
deviation was used for quantitative variables and
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frequency and percentage for qualitative variables.
Distribution of variables was compared between cases
and controls; comparison of qualitative variables was
done by chi-square test and of quantitative variables by
independent sample t-test and analysis of variance
value of < 0.05 was taken as significant. Subgroup
analysis was done to see association of exposure (use
of diuretics) and with hyponatremia, stratified for age,
gender, IHD, CKD and CLD to check for confounding.
Crude odds ratio and its 95% confidence interval (95%
CI) were computed through logistic regression for each
independent variable. Multiple logistic regression
models were built to determine the association of
exposure (use of diuretics) with hyponatremia.
A sample of 1800 participants was drawn during the
study period. Out of these, 1191 (66) fulfilled the
inclusion criteria. Cases n (%) (hypertensives with
hyponatremia) on admission were 552 (46.3) and
controls (hypertensives without hyponatremia) were 639
(53.7). All participants were followed back in time for
exposure of being on diuretics versus not on diuretics.
Mean age was 62.5 ± 12.4 years; 65.8 ± 11.1 years in
cases and 59.6 ± 11.1 years in controls. Males were 540
(45.3%); 197 (35.6%) in cases and 343 (53.8%) in
controls. Mean systolic blood pressure was 136.2 ± 25
mmHg; 137.0 ± 26 mmHg in cases and 135.5 ± 24.3
mmHg in controls. Mean sodium was 133.1 ± 9.4 meq/L;
126 ± 9.9 meq/L in cases and 139 ± 2.5 meq/L in
controls. Overall prevalence of hypertensives on
diuretics was 369 (30.9%). Out of them, 126 (34.1%)
were on loop diuretics, 73 (19.7%) were on loop +
potassium sparing diuretics, 47 (12.7%) were on
thiazide diuretic, 15 (4%) were on potassium sparing
diuretic. Among cases (n=552), 300 (54.3%) had mild
hyponatremia, 162 (22.3%) had moderate hyponatremia
and 90 (7.5%) had severe hyponatremia.
Among cases, 180 (32.5%) were exposed (on diuretics)
and in controls, 189 (29.6%) were exposed (on diuretics,
p-value 0.15). Mean sodium level in exposed group
was125.4 ± 9.1 meq/L in cases and 139.3 ± 2.22 meq/L
in exposed group in controls. OR of having
hyponatremia and being exposed was 1.14 (95% CI;
0.89 - 1.46, p=0.27). On further stratification of the
exposed group (on diuretics); there was no statistically
significant difference with age > 63 years (58.3 years vs.
39.7 years; p < 0.19) and female gender (65% vs.
46.6%, p=0.35, Table I). On subgroup analysis of the
exposed group into those who were on thiazide diuretics
versus those on other diuretic the association was not
significant with hyponatremia. (17% vs. 19.4% {OR 1.16
(0.61 - 2.18) p=0.63}.
On logistic regression analysis taking outcome
hyponatremia; OR (95% LCI, UCI) for association of
having hyponatremia with exposure was 1.13 (0.87,
1.46, p=0.33) after adjusting for age and gender in
model 1. Further adjustment for CKD, IHD and CLD is
shown in model 2, 3 and 4 respectively (Table II). No
significant association is shown of having hyponatremia
with exposure in the final model; OR (95% CI) 1.11
(0.86 - 1.45; p=0.40).
Diuretics make up one of the most common causes of
hyponatremia, with an estimated incidence of 11% in 1
series of 114 geriatric patients.7 It was found in this study
that the association of hyponatremia with diuretic use in
hypertensive is not significant in adults. However, there
was significant hyponatrermia in elderly and female
patients. In the Systolic Hypertension in the Elderly
Program (SHEP), which focused on older patients,
hyponatremia was observed in 4.1% of patients treated
with chlorthalidone versus 1.3% in the control group.8 In
this study, this proportion of patients showed no
significant association with hyponatremia The reason for
this could also be that primarily 3 main factors;
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Table I: Association of hyponatremia with diuretic use in hypertensive
patients^.
Variables Cases on diuretics Controls on diuretics OR(95%CI) p-value
(exposed) (exposed)
n=180 n=189
%  (n) %  (n)
Age: > 63 years 58.3 (105) 39.7 (75) 1.34 (0.85,2.11) 0.19
Gender: female 65 (117) 46.6 (88) 0.80 (0.51,1.27) 0.35
CKD 13.9 (25) 11.1 (21) 1.19 (0.59,2.4) 0.61
IHD 38.3 (69) 45 (85) 1.00 (0.63,1.5) 0.98
CLD* 10 (18) 5.8 (11) - -
^ Continuous variables are reported as mean ± standard deviation, and categorical variables
are reported as %(n) CKD : Chronic kidney disease, IHD : Ischemic heart disease,
CLD : Chronic liver disease.*OR was in exponential value.
Table II: Regression models for factors associated with hyponatremia in hypertensives.
Candidate variables Model 1* Model 2** Model 3*** Model 4****
OR(95%CI) p-value OR(95%CI) p-value OR(95%CI) p-value OR(95%CI) p-value
Diuretic use 1.13(0.87,1.46) 0.33 1.12 (0.87,1.45) 0.36 1.15 (0.88,1.48) 0.29 1.11 (0.86,1.45) 0.40
Age: > 63 years 2.41(1.90,3.05) < 0.001 2.40 (1.89,3.05) < 0.001 2.46 (1.93,3.13) < 0.001 2.49 (1.96,3.17) < 0.001
Male: gender 0.47(0.37,0.60) < 0.001 0.47 (0.37,0.60) < 0.001 0.48 (0.38,0.61) < 0.001 0.49 (0.38,0.62) < 0.001
CKD - - 1.14 (0.75,1.73) 0.53 1.13 (0.74,1.71) 0.56 1.11 (0.73,1.69) 0.61
IHD - - - - 0.81 (0.63,1.05) 0.11 0.83 (0.64,1.07) 0.15
CLD - - - - - - 1.78 (1.0,3.16) 0.04
Outcome; cases (hypertensives with electrolyte imbalance) / controls (hypertensives without electrolyte imbalance).
Model I* adjusted for age > 63 years and gender.
Model 2** adjusted for age > 63 years, gender and Chronic kidney disease (CKD).
Model 3*** adjusted for age > 63 years, gender, CKD and ischemic heart disease (IHD).
Model 4**** adjusted for age > 63 years, gender, CKD : Chronic kidney disease, IHD : Ischemic heart disease, CLD : Chronic liver disease.
Hosmer lameshow test:0.12.
stimulation of vasopressin secretion, reduced free-water
clearance, and increased water intake all contribute in
development of thiazide induced hyponatremia.9
Any change in these factors can hence confound the
effect of thiazide induced hyponatremia. The risk of
thiazide induced hyponatremia is 3-fold higher in
patients older than 70 years and is higher among
women, possibly because of smaller body size or lower
sodium intake.10 In a study of Chinese population, in
2759 Chinese population thiazides were associated
with low prevalence of hyponatremia and hence it was
recommended that physicians should not deter from
prescribing thiazide diuretics as first-line antihyper-
tensive agents as recommended by most international
guidelines.4
The strength of the study is the large sample size and a
case control design. It is the first to report the
association of diuretics with hyponatremia in a multi-
variable model. However, there are several limitations in
this study. Firstly, the group on thiazide diuretic is very
small, hence the entire results cannot be related largely
to them. Secondly, information regarding the different
dosages of diuretics has not been recorded which may
be a confounder. Thirdly, contribution of other agents
causing hyponatremia like antidepressants causing
hyponatremia has not been recorded.
It is concluded that diuretics are not associated with
hyponatremia in hypertensive adult patients in this
cohort of patients. However, elderly population on
diuretics is more likely to have hyponatremia compared
to the adult population. The use of thiazide diuretics is
very low in this patient population. The authors
recommend that a randomized parallel arm trial
comparing thiazide diuretics with other antihyper-
tensives be done to establish whether thiazides are
associated with hyponatremia in this patient population.
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